Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -5.10%95.33M | -45.87%57.93M | -2.54%161.41M | -29.73%96.61M | -57.43%100.45M | -72.21%107.02M | -69.01%165.62M | -78.52%137.5M | -64.42%235.98M | -51.49%385.17M |
| Transactional financial assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.2K | ---- | ---- |
| Notes receivable and accounts receivable | -21.93%68.44M | -19.17%68.63M | -20.75%74.71M | -9.21%82.66M | -13.19%87.67M | -28.02%84.91M | -39.55%94.28M | -24.89%91.05M | -40.18%100.98M | -29.92%117.96M |
| -Notes receivable | 17.94%440.05K | 12.05%368.85K | -63.13%124.97K | -0.82%355.65K | -50.35%373.13K | -44.14%329.19K | 5.18%338.96K | -58.60%358.58K | -18.33%751.51K | -48.11%589.32K |
| -Accounts receivable | -22.10%68M | -19.29%68.26M | -20.60%74.59M | -9.25%82.3M | -12.91%87.29M | -27.94%84.58M | -39.64%93.94M | -24.65%90.69M | -40.30%100.23M | -29.80%117.37M |
| Other receivables (including interest and dividends) | 20.80%40.85M | 6.35%34.59M | 160.73%33.47M | 208.89%30.34M | -19.28%33.82M | -9.05%32.52M | -71.94%12.84M | -70.03%9.82M | -15.50%41.89M | -3.41%35.76M |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --884.4K |
| -Other receivable | ---- | 6.35%34.59M | ---- | ---- | ---- | -6.74%32.52M | ---- | -70.03%9.82M | ---- | -5.80%34.87M |
| Advance payment | -55.63%7.77M | -59.17%7.19M | 63.57%8.32M | -29.17%8.33M | -19.68%17.5M | -38.68%17.61M | -65.08%5.08M | -51.54%11.76M | 78.56%21.79M | 110.64%28.72M |
| Inventories | 24.91%1.08B | 19.03%1.02B | 8.54%911.19M | 8.53%928.1M | 7.58%863.51M | 12.31%856.83M | 29.40%839.5M | 44.34%855.15M | 35.27%802.69M | 26.24%762.95M |
| Non-current assets due within one year | --7.08K | --19.5K | --39.64K | --61.85K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | 17.45%20.59M | 62.94%26.03M | 143.86%16.17M | 162.52%19.98M | 141.05%17.53M | 69.53%15.97M | -2.92%6.63M | -19.77%7.61M | 18.48%7.27M | 31.58%9.42M |
| Total current assets | 17.06%1.31B | 8.91%1.21B | 7.24%1.21B | 4.78%1.17B | -7.45%1.12B | -16.80%1.11B | -22.82%1.12B | -21.64%1.11B | -18.94%1.21B | -17.52%1.34B |
| Non Current assets | ||||||||||
| Other non-current financial assets | --2.01M | --1.25M | --1.2M | --1.29M | ---- | ---- | ---- | ---- | ---- | ---- |
| Investment real estate | ---- | ---- | ---- | ---- | -17.12%752.15K | -16.41%790.98K | -15.77%829.81K | -15.17%868.64K | -14.61%907.47K | -14.10%946.3K |
| Fixed assets | ---- | -2.07%893.52M | ---- | ---- | ---- | 52.67%912.38M | ---- | 64.08%942.29M | ---- | 49.60%597.62M |
| Constru in process | ---- | -59.34%8.46M | ---- | ---- | ---- | -85.71%20.81M | ---- | -12.71%18.2M | ---- | 9.58%145.68M |
| Productive biological assets | -17.04%163.83M | -0.31%185.44M | 10.85%202.18M | 16.38%193.7M | 14.58%197.49M | 6.77%186.02M | -4.22%182.39M | 3.96%166.44M | 41.32%172.36M | 76.85%174.22M |
| Intangible assets | -2.75%22.8M | -4.21%22.67M | -2.69%23.29M | -4.25%23.17M | -9.37%23.44M | -9.57%23.67M | -9.41%23.94M | -4.34%24.2M | -4.40%25.87M | -4.43%26.17M |
| Long deferred expense | -8.43%179M | 48.81%191.23M | 55.74%183.1M | 54.24%200.74M | 53.33%195.48M | 58.88%128.51M | 280.94%117.57M | 294.82%130.14M | 263.57%127.49M | 131.15%80.89M |
| Deferred tax assets | -34.89%6.33M | -34.91%6.33M | -42.01%6.52M | -42.02%6.52M | 200.63%9.73M | 200.87%9.73M | 248.33%11.24M | -30.83%11.24M | -35.03%3.24M | -35.07%3.23M |
| Usufruct assets | -45.96%34.04M | -42.09%35.78M | -50.92%36.72M | -50.65%38.52M | -15.88%62.99M | -17.28%61.78M | 1.53%74.81M | 13.55%78.07M | 21.89%74.88M | 13.87%74.69M |
| Other non current assets | -34.94%50.97M | -30.97%54.08M | -24.59%59.08M | -24.59%59.08M | -29.21%78.34M | -39.35%78.34M | -44.51%78.34M | -44.51%78.34M | -29.14%110.67M | -21.91%129.17M |
| Total non current assets | -9.13%1.36B | -1.64%1.4B | -1.91%1.42B | -1.02%1.43B | 5.48%1.49B | 15.37%1.42B | 34.24%1.44B | 39.31%1.45B | 44.57%1.41B | 32.48%1.23B |
| Total assets | 2.10%2.67B | 3.00%2.61B | 2.09%2.62B | 1.50%2.6B | -0.48%2.61B | -1.39%2.54B | 1.42%2.57B | 4.14%2.56B | 6.19%2.62B | 0.69%2.57B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | ---- | --80.04M | --80.05M | --80.05M | --79.97M | ---- | ---- | ---- | ---- | ---- |
| Notes payable and accounts payable | 11.89%87.06M | 27.54%77.36M | -2.80%63.02M | -6.98%68.89M | 4.84%77.81M | -11.98%60.65M | -30.23%64.83M | 1.52%74.06M | 3.38%74.22M | -5.33%68.91M |
| -Accounts payable | 11.89%87.06M | 27.54%77.36M | -2.80%63.02M | -6.98%68.89M | 4.84%77.81M | -11.98%60.65M | -30.23%64.83M | 1.52%74.06M | 3.38%74.22M | -5.33%68.91M |
| Contract liabilities | 168.26%14.77M | 75.33%6.9M | -3.14%5.5M | -20.62%4.9M | 74.33%5.51M | -24.06%3.93M | 17.69%5.68M | 53.02%6.18M | -46.49%3.16M | -27.44%5.18M |
| Advance receipts | -0.81%27.83M | 6.31%30.22M | -0.49%28.9M | -3.37%28.42M | -7.36%28.06M | -4.64%28.43M | -1.59%29.04M | 1.30%29.41M | 3.58%30.29M | 4.27%29.81M |
| Salaries payable | 5.11%21.51M | -1.68%21.61M | 2.01%21.92M | 5.88%25M | 5.07%20.47M | 3.63%21.98M | 1.18%21.48M | 37.44%23.61M | -5.93%19.48M | -10.54%21.21M |
| Taxs payable | 1.93%6.98M | -3.73%7.41M | 26.91%8.27M | -28.86%7.18M | -30.18%6.85M | -40.00%7.7M | 20.81%6.52M | -21.56%10.09M | -57.81%9.81M | -46.09%12.83M |
| Other payable (including interest and dividends) | 1.54%127.4M | -15.75%123.15M | 2.18%128.69M | -2.98%124.33M | -3.63%125.47M | 18.63%146.17M | 119.12%125.94M | 35.52%128.14M | 120.26%130.2M | 44.45%123.22M |
| -Interest payable | ---- | ---- | ---- | ---- | --71.09K | ---- | ---- | ---- | ---- | ---- |
| -Dividend payable | 0.00%87K | -99.65%87K | --87K | 0.00%87K | 0.00%87K | 28,381.04%24.78M | ---- | 0.00%87K | --87K | 0.00%87K |
| -Other payable | ---- | 1.38%123.06M | ---- | ---- | --125.31M | -1.41%121.39M | ---- | 35.55%128.05M | ---- | 44.67%123.13M |
| Non current liabilities due within one year | 1.25%7.57M | -5.74%8M | -4.67%8.14M | -34.72%6.32M | -17.70%7.47M | -22.67%8.49M | -16.26%8.54M | -28.30%9.69M | -30.18%9.08M | -17.40%10.98M |
| Other current liabilities | 0.00%928.52K | 0.00%928.52K | 0.22%930.53K | 47.14%1.37M | 0.00%928.52K | -8.74%928.52K | 0.00%928.52K | 0.00%928.52K | 0.00%928.52K | 9.58%1.02M |
| Total current liabilities | -16.59%294.05M | 27.79%355.62M | 31.36%345.43M | 22.81%346.45M | 27.19%352.53M | 1.88%278.28M | 18.19%262.97M | 15.12%282.1M | 23.77%277.16M | -23.17%273.15M |
| Current liabilities | ||||||||||
| Long term loan | --100.08M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Estimate liabilities | -31.94%13.05M | -31.94%13.05M | -31.94%13.05M | -31.94%13.05M | 0.00%19.18M | 0.00%19.18M | 0.00%19.18M | 0.00%19.18M | --19.18M | --19.18M |
| Deferred tax liabilities | -47.83%5M | -47.83%5M | -51.54%5.45M | -51.54%5.45M | 340.43%9.58M | 340.43%9.58M | 416.68%11.24M | -28.18%11.24M | -11.18%2.18M | -11.18%2.18M |
| Long term deferred income | 17.06%24.98M | 18.57%24.57M | 19.55%23.7M | 18.23%22.52M | 28.63%21.34M | 31.14%20.72M | 39.00%19.82M | 46.45%19.05M | 28.66%16.59M | 28.02%15.8M |
| Lease liabilities | -54.55%25.23M | -46.32%28.68M | -55.56%28.48M | -49.94%31.74M | -11.21%55.5M | -10.52%53.44M | 8.20%64.09M | 22.24%63.41M | 36.64%62.51M | 21.82%59.72M |
| Total non current liabilities | 59.42%168.33M | -30.72%71.3M | -38.18%70.68M | -35.53%72.77M | 5.12%105.59M | 6.24%102.91M | 20.54%114.33M | 13.21%112.88M | 64.43%100.44M | 51.80%96.87M |
| Total liabilities | 0.93%462.39M | 12.00%426.92M | 10.29%416.11M | 6.14%419.22M | 21.32%458.12M | 3.02%381.19M | 18.89%377.3M | 14.57%394.97M | 32.48%377.61M | -11.76%370.02M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%818.7M | 0.00%818.7M | 0.00%818.7M | 0.00%818.7M | 0.00%818.7M | 0.00%818.7M | 0.00%818.7M | 0.00%818.7M | 0.00%818.7M | 0.00%818.7M |
| Capital reserve funds | 0.00%297.67M | 0.00%297.67M | 0.00%297.67M | 0.00%297.67M | 0.00%297.67M | 0.00%297.67M | 0.00%297.67M | 0.00%297.67M | 0.00%297.67M | 0.00%297.67M |
| Surplus reserve funds | 0.00%163.74M | 0.00%163.74M | 0.00%163.74M | 0.00%163.74M | 0.00%163.74M | 0.00%163.74M | 0.00%163.74M | 0.00%163.74M | 12.53%163.74M | 12.53%163.74M |
| Retained profit | 5.35%895.42M | 2.99%877.21M | 1.40%896.7M | 1.35%872.72M | -8.69%849.96M | -4.01%851.76M | -1.49%884.33M | 6.74%861.14M | 5.44%930.87M | 6.70%887.34M |
| Shareholders equity without minority interests | 2.13%2.18B | 1.19%2.16B | 0.57%2.18B | 0.54%2.15B | -3.66%2.13B | -1.64%2.13B | -0.61%2.16B | 2.61%2.14B | 3.09%2.21B | 3.53%2.17B |
| Minority interests | 21.98%28.84M | 20.69%28.78M | 9.80%28.76M | 9.65%28.99M | -34.21%23.64M | -32.11%23.85M | -28.80%26.19M | -9.61%26.44M | -13.89%35.94M | -16.59%35.13M |
| Total shareholder equity | 2.35%2.2B | 1.41%2.19B | 0.68%2.21B | 0.65%2.18B | -4.15%2.15B | -2.13%2.16B | -1.08%2.19B | 2.44%2.17B | 2.76%2.25B | 3.14%2.2B |
| Total liabilityies and equity | 2.10%2.67B | 3.00%2.61B | 2.09%2.62B | 1.50%2.6B | -0.48%2.61B | -1.39%2.54B | 1.42%2.57B | 4.14%2.56B | 6.19%2.62B | 0.69%2.57B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- |
| Auditor | -- | -- | -- | Yongtuo Certified Public Accountants (Special General Partnership) | -- | -- | -- | Yongtuo Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.